NRX Pharmaceuticals Inc (FRA:B1Q)
€ 4.86 0 (0%) Market Cap: 12.64 Mil Enterprise Value: 18.01 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Q2 2021 NRX Pharmaceuticals Inc Earnings Call Transcript

Aug 17, 2021 / 12:30PM GMT
Release Date Price: €119 (-6.30%)
Operator

Greetings, and welcome to the NRx Pharma second-quarter 2021 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your hosts, Eric Goldstein, Managing Director, LifeSci Advisors. Thank you. You may begin.

Eric Goldstein
LifeSci Advisors - Managing Director

Thank you, operator. Before we proceed with the call, I'd like to remind everyone that certain statements made during this call are forward-looking statements under US federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the Securities & Exchange Commission.

The forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot